Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Bauer

Showing results (141-150 of 171) with videos related to

Pageof 18
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 27, 2026
Trop-2.2 directed radioimmunotherapy with 177Lu, 225Ac, and 212Pb in a pancreatic cancer modelEdwin C Pratt, David Bauer, Lukas M Carter, et al.
Journal of Medicinal Chemistry|April 18, 2018
N<sup>ε</sup>-Acryloyllysine Piperazides as Irreversible Inhibitors of Transglutaminase 2: Synthesis, Structure-Activity Relationships, and Pharmacokinetic ProfilingRobert Wodtke, Christoph Hauser, Gloria Ruiz-Gómez, et al.
United European Gastroenterology Journal|September 4, 2020
Soluble guanylyl cyclase stimulation and phosphodiesterase-5 inhibition improve portal hypertension and reduce liver fibrosis in bile duct-ligated ratsKsenia Brusilovskaya, Philipp Königshofer, Daniel Lampach, et al.
Plos One|January 10, 2018
Transjugular intrahepatic portosystemic shunts (TIPS) for the prevention of variceal re-bleeding - A two decades experienceTheresa Bucsics, Maria Schoder, Magdalena Diermayr, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 5, 2017
Re-bleeding rates and survival after early transjugular intrahepatic portosystemic shunt (TIPS) in clinical practiceTheresa Bucsics, Maria Schoder, Nicolas Goeschl, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 26, 2026
Delta-like Ligand 3-Directed <sup>225</sup>Ac Radioimmunotherapy in Neuroendocrine Lung and Prostate Cancer ModelsTran T Hoang, David Bauer, Aidan Ingham, et al.
Tetrahedron|July 20, 2010
Spongipyran Synthetic Studies. Evolution of a Scalable Total Synthesis of (+)-Spongistatin 1Amos B Smith, Chris Sfouggatakis, Christina A Risatti, et al.
Journal of Hepatology|January 23, 2022
Factor VIII/protein C ratio independently predicts liver-related events but does not indicate a hypercoagulable state in ACLDBernhard Scheiner, Lorenz Balcar, Rosa Johanna Nussbaumer, et al.
Alimentary Pharmacology & Therapeutics|November 6, 2025
Indocyanine Green Clearance Correlates With Biomarkers Reflecting Key Disease-Driving Mechanisms in Advanced Chronic Liver Disease and Predicts Acute-on-Chronic Liver Failure and DeathMathias Jachs, Tânia Carvalho, Benedikt Simbrunner, et al.
The Lancet. Neurology|November 3, 2009
Integration of genetic risk factors into a clinical algorithm for multiple sclerosis susceptibility: a weighted genetic risk scorePhilip L De Jager, Lori B Chibnik, Jing Cui, et al.
Pageof 18

Showing results (141-150 of 171) with videos related to

Sort By:
Pageof 18
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 27, 2026
Trop-2.2 directed radioimmunotherapy with 177Lu, 225Ac, and 212Pb in a pancreatic cancer modelEdwin C Pratt, David Bauer, Lukas M Carter, et al.
Journal of Medicinal Chemistry|April 18, 2018
N<sup>ε</sup>-Acryloyllysine Piperazides as Irreversible Inhibitors of Transglutaminase 2: Synthesis, Structure-Activity Relationships, and Pharmacokinetic ProfilingRobert Wodtke, Christoph Hauser, Gloria Ruiz-Gómez, et al.
United European Gastroenterology Journal|September 4, 2020
Soluble guanylyl cyclase stimulation and phosphodiesterase-5 inhibition improve portal hypertension and reduce liver fibrosis in bile duct-ligated ratsKsenia Brusilovskaya, Philipp Königshofer, Daniel Lampach, et al.
Plos One|January 10, 2018
Transjugular intrahepatic portosystemic shunts (TIPS) for the prevention of variceal re-bleeding - A two decades experienceTheresa Bucsics, Maria Schoder, Magdalena Diermayr, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 5, 2017
Re-bleeding rates and survival after early transjugular intrahepatic portosystemic shunt (TIPS) in clinical practiceTheresa Bucsics, Maria Schoder, Nicolas Goeschl, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 26, 2026
Delta-like Ligand 3-Directed <sup>225</sup>Ac Radioimmunotherapy in Neuroendocrine Lung and Prostate Cancer ModelsTran T Hoang, David Bauer, Aidan Ingham, et al.
Tetrahedron|July 20, 2010
Spongipyran Synthetic Studies. Evolution of a Scalable Total Synthesis of (+)-Spongistatin 1Amos B Smith, Chris Sfouggatakis, Christina A Risatti, et al.
Journal of Hepatology|January 23, 2022
Factor VIII/protein C ratio independently predicts liver-related events but does not indicate a hypercoagulable state in ACLDBernhard Scheiner, Lorenz Balcar, Rosa Johanna Nussbaumer, et al.
Alimentary Pharmacology & Therapeutics|November 6, 2025
Indocyanine Green Clearance Correlates With Biomarkers Reflecting Key Disease-Driving Mechanisms in Advanced Chronic Liver Disease and Predicts Acute-on-Chronic Liver Failure and DeathMathias Jachs, Tânia Carvalho, Benedikt Simbrunner, et al.
The Lancet. Neurology|November 3, 2009
Integration of genetic risk factors into a clinical algorithm for multiple sclerosis susceptibility: a weighted genetic risk scorePhilip L De Jager, Lori B Chibnik, Jing Cui, et al.
Pageof 18